Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources
Competitive Landscape Some of the Key Players in GLP-1 Market: AstraZeneca plc Boehringer Ingelheim International GmbH Eli Lilly and Company Innogen Pharmaceutical Technology Co., Ltd
Differences between GLP-1 receptor agonists and DPP-4 inhibitors[1] Glucagon-like peptide-1 receptor (GLP-1R) is a critical therapeutic target for type 2 diabetes mellitus (T2DM)
It has been shown to have a protective and healing effect on the entire gastrointestinal tract
Its absolutely okay to use vitamin C every day
Folic Acid Helps prevent neural tube defects, supports cell growth, and reduces risk of preterm birth